Page last updated: 2024-08-16

tibolone and Venous Thromboembolism

tibolone has been researched along with Venous Thromboembolism in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abildgaard, U; Andresen, MS; Eilertsen, AL; Sandset, PM	1
Kluft, C	1

Reviews

1 review(s) available for tibolone and Venous Thromboembolism

Article	Year
Effects of hormone treatment on hemostasis variables. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10 Suppl 2 Topics: Administration, Oral; Administration, Topical; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Hemostasis; Humans; Inflammation; Norpregnenes; Progestins; Raloxifene Hydrochloride; Tamoxifen; Venous Thromboembolism	2007

Article

Year

Effects of hormone treatment on hemostasis variables.

Climacteric : the journal of the International Menopause Society, 2007, Volume: 10 Suppl 2

Topics: Administration, Oral; Administration, Topical; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Hemostasis; Humans; Inflammation; Norpregnenes; Progestins; Raloxifene Hydrochloride; Tamoxifen; Venous Thromboembolism

2007

Trials

1 trial(s) available for tibolone and Venous Thromboembolism

Article	Year
Hormone therapy and raloxifene reduce the coagulation inhibitor potential. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2007, Volume: 18, Issue:5 Topics: Aged; Blood Coagulation; Estrogen Antagonists; Estrogen Replacement Therapy; Factor V; Female; Fibrin; Heterozygote; Humans; Middle Aged; Mutation; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Thrombophilia; Venous Thromboembolism	2007

Article

Year

Hormone therapy and raloxifene reduce the coagulation inhibitor potential.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2007, Volume: 18, Issue:5

Topics: Aged; Blood Coagulation; Estrogen Antagonists; Estrogen Replacement Therapy; Factor V; Female; Fibrin; Heterozygote; Humans; Middle Aged; Mutation; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Thrombophilia; Venous Thromboembolism

2007